A2M | Alpha-2-macroglobulin | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images/2265/if_selected_60x60.jpg) | ![](/images/2265/ihc_cell_selected_60x60.jpg) | ![](/images/2265/7604_A_2_2_rna_selected_60x60.jpg) | Expressed in all |
ACE | Angiotensin I converting enzyme | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/2426/ihc_cell_selected_60x60.jpg) | ![](/images/2426/6196_B_7_3_rna_selected_60x60.jpg) | Group enriched |
ADIPOQ | Adiponectin, C1Q and collagen domain containing | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/46467/ihc_cell_selected_60x60.jpg) | ![](/images/46467/104620_B_9_2_rna_selected_60x60.jpg) | Tissue enriched |
ALB | Albumin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/6262/17726_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
ALDOC | Aldolase C, fructose-bisphosphate | Cancer-related genes Candidate cardiovascular disease genes Cytoskeleton related proteins Enzymes Plasma proteins
| | ![](/images/3282/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/20828/49910_B_3_3_rna_selected_60x60.jpg) | Expressed in all |
APOA1 | Apolipoprotein A-I | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images/46715/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/16778/39552_B_8_5_rna_selected_60x60.jpg) | Group enriched |
APOA4 | Apolipoprotein A-IV | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | | ![](/images/2549/ihc_cell_selected_60x60.jpg) | ![](/images/1352/3295_B_9_3_rna_selected_60x60.jpg) | Group enriched |
APOB | Apolipoprotein B | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/49793/141695_B_9_3_rna_selected_60x60.jpg) | Group enriched |
APOC2 | Apolipoprotein C-II | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/55877/127848_B_8_4_rna_selected_60x60.jpg) | Tissue enriched |
APOE | Apolipoprotein E | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8363/20779_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
APOH | Apolipoprotein H (beta-2-glycoprotein I) | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3732/11044_B_9_3_rna_selected_60x60.jpg) | Tissue enriched |
APOL1 | Apolipoprotein L, 1 | Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/18885/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/18885/42224_B_5_5_rna_selected_60x60.jpg) | Expressed in all |
BDH1 | 3-hydroxybutyrate dehydrogenase, type 1 | Candidate cardiovascular disease genes Enzymes Mitochondrial proteins
| | | ![](/images_static/rna_center.gif) | ![](/images/30947/72611_B_9_1_rna_selected_60x60.jpg) | Expressed in all |
C3 | Complement component 3 | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images/20432/if_selected_60x60.jpg) | ![](/images/4209/ihc_cell_selected_60x60.jpg) | ![](/images/4209/12200_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
C4A | Complement component 4A (Rodgers blood group) | Blood group antigen proteins Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/50103/120025_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
C4B | Complement component 4B (Chido blood group) | Blood group antigen proteins Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46356/120006_B_3_8_rna_selected_60x60.jpg) | Expressed in all |
CD40LG | CD40 ligand | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins
| | ![](/images/45827/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/45827/105628_A_2_2_rna_selected_60x60.jpg) | Tissue enhanced |
CHGA | Chromogranin A (parathyroid secretory protein 1) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images/17369/if_selected_60x60.jpg) | | ![](/images/17369/141312_A_1_1_rna_selected_60x60.jpg) | Tissue enhanced |
CHIT1 | Chitinase 1 (chitotriosidase) | Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/10575/25814_A_2_7_rna_selected_60x60.jpg) | Group enriched |
CKB | Creatine kinase, brain | Cancer-related genes Candidate cardiovascular disease genes Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/47313/104793_A_1_6_rna_selected_60x60.jpg) | Expressed in all |
CKM | Creatine kinase, muscle | Candidate cardiovascular disease genes Enzymes FDA approved drug targets Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/47859/107889_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
CP | Ceruloplasmin (ferroxidase) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/8591/22285_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
CRP | C-reactive protein, pentraxin-related | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/5036/ihc_cell_selected_60x60.jpg) | ![](/images/5036/15290_B_9_3_rna_selected_60x60.jpg) | Group enriched |
CTSB | Cathepsin B | Cancer-related genes Candidate cardiovascular disease genes Enzymes Plasma proteins Predicted secreted proteins
| ![](/images/18156/ihc_selected_60x60.jpg) | | | ![](/images/18156/41695_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
EDN1 | Endothelin 1 | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images/31976/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/31976/66915_A_1_6_rna_selected_60x60.jpg) | Mixed |
ENG | Endoglin | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Plasma proteins Predicted membrane proteins
| | | | ![](/images/96/1439_B_7_6_rna_selected_60x60.jpg) | Expressed in all |
ENO2 | Enolase 2 (gamma, neuronal) | Cancer-related genes Candidate cardiovascular disease genes Enzymes Plasma proteins
| | ![](/images_static/na_center.gif) | | ![](/images/63/1638_A_3_3_rna_selected_60x60.jpg) | Expressed in all |
ENO3 | Enolase 3 (beta, muscle) | Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets
| ![](/images/793/ihc_selected_60x60.jpg) | | ![](/images/793/ihc_cell_selected_60x60.jpg) | ![](/images/793/1796_A_2_3_rna_selected_60x60.jpg) | Tissue enriched |
F12 | Coagulation factor XII (Hageman factor) | Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3825/11032_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
F13A1 | Coagulation factor XIII, A1 polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets
| | | ![](/images_static/rna_center.gif) | ![](/images/1804/5950_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
F13B | Coagulation factor XIII, B polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3827/10806_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
F2 | Coagulation factor II (thrombin) | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/54698/133719_B_9_1_rna_selected_60x60.jpg) | Tissue enriched |
F3 | Coagulation factor III (thromboplastin, tissue factor) | Cancer-related genes Candidate cardiovascular disease genes CD markers Plasma proteins Predicted membrane proteins
| ![](/images/9438/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/9438/27292_B_9_4_rna_selected_60x60.jpg) | Expressed in all |
F8 | Coagulation factor VIII, procoagulant component | Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/18777/41663_B_8_2_rna_selected_60x60.jpg) | Expressed in all |
FABP3 | Fatty acid binding protein 3, muscle and heart (mammary-derived growth inhibitor) | Candidate cardiovascular disease genes Plasma proteins
| | ![](/images/55754/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/55754/134905_B_8_2_rna_selected_60x60.jpg) | Group enriched |
FAS | Fas cell surface death receptor | Cancer-related genes Candidate cardiovascular disease genes CD markers Disease related genes Predicted membrane proteins Predicted secreted proteins
| ![](/images/27444/ihc_selected_60x60.jpg) | | ![](/images_static/rna_center.gif) | ![](/images/27444/61484_B_8_5_rna_selected_60x60.jpg) | Expressed in all |
FGA | Fibrinogen alpha chain | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/51370/141892_B_8_2_rna_selected_60x60.jpg) | Tissue enriched |
FGB | Fibrinogen beta chain | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/1901/6360_B_8_1_rna_selected_60x60.jpg) | Tissue enriched |
FGF2 | Fibroblast growth factor 2 (basic) | Cancer-related genes Candidate cardiovascular disease genes FDA approved drug targets RAS pathway related proteins
| ![](/images/125/ihc_selected_60x60.jpg) | | | ![](/images/125/2186_A_5_8_rna_selected_60x60.jpg) | Mixed |
FGG | Fibrinogen gamma chain | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Plasma proteins Predicted secreted proteins
| | ![](/images/27529/if_selected_60x60.jpg) | ![](/images_static/rna_center.gif) | ![](/images/27529/59691_B_8_6_rna_selected_60x60.jpg) | Tissue enriched |
FN1 | Fibronectin 1 | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | | ![](/images/126/2145_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
FTL | Ferritin, light polypeptide | Cancer-related genes Candidate cardiovascular disease genes Disease related genes FDA approved drug targets Plasma proteins
| | ![](/images/41602/if_selected_60x60.jpg) | | ![](/images/20769/47941_A_1_6_rna_selected_60x60.jpg) | Expressed in all |
GFAP | Glial fibrillary acidic protein | Candidate cardiovascular disease genes Disease related genes Plasma proteins
| | ![](/images_static/na_center.gif) | ![](/images/39/ihc_cell_selected_60x60.jpg) | ![](/images/56030/135458_A_6_7_rna_selected_60x60.jpg) | Tissue enriched |
GGT1 | Gamma-glutamyltransferase 1 | Candidate cardiovascular disease genes CD markers Disease related genes Enzymes Plasma proteins Potential drug targets Predicted membrane proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/45635/103738_A_9_6_rna_selected_60x60.jpg) | Tissue enhanced |
GOT2 | Glutamic-oxaloacetic transaminase 2, mitochondrial | Cancer-related genes Candidate cardiovascular disease genes Enzymes Mitochondrial proteins Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images/18139/ihc_cell_selected_60x60.jpg) | ![](/images/18139/41976_B_8_1_rna_selected_60x60.jpg) | Expressed in all |
HP | Haptoglobin | Cancer-related genes Candidate cardiovascular disease genes Disease related genes Enzymes Plasma proteins Potential drug targets Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/3787/10338_A_2_1_rna_selected_60x60.jpg) | Tissue enriched |
HPX | Hemopexin | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins Transporters
| | ![](/images_static/na_center.gif) | ![](/images/16725/ihc_cell_selected_60x60.jpg) | ![](/images/16725/37192_B_7_4_rna_selected_60x60.jpg) | Tissue enriched |
ICAM1 | Intercellular adhesion molecule 1 | Cancer-related genes Candidate cardiovascular disease genes CD markers FDA approved drug targets Plasma proteins Predicted membrane proteins Predicted secreted proteins
| | ![](/images/2142/if_selected_60x60.jpg) | | ![](/images/2142/5934_B_7_3_rna_selected_60x60.jpg) | Expressed in all |
IGFBP1 | Insulin-like growth factor binding protein 1 | Candidate cardiovascular disease genes Plasma proteins Predicted secreted proteins
| | ![](/images_static/na_center.gif) | ![](/images_static/rna_center.gif) | ![](/images/46972/146495_B_7_7_rna_selected_60x60.jpg) | Group enriched |
IL18 | Interleukin 18 (interferon-gamma-inducing factor) | Cancer-related genes Candidate cardiovascular disease genes Plasma proteins
| | | | ![](/images/3980/13222_A_2_2_rna_selected_60x60.jpg) | Expressed in all |